文献速递贫血与红细胞疾病浆细胞疾病

下呼吸道淀粉样变性:表现、生存与预后因素的多中心连续病例系列

Lower respiratory tract amyloidosis: Presentation, survival and prognostic factors. A multicenter consecutive case series.
PubMed 文献 · Am J Hematol · 2019-08-23

该多中心回顾性研究纳入1995至2017年73例下呼吸道淀粉样变性患者,按气管支气管、结节、间质或复合模式分型。间质和复合型多与多器官淀粉样变性相关,气管支气管和结节型多与器官局限型相关;AL型占59%。心脏受累、年龄和诊断时呼吸困难是独立死亡危险因素。

要点

  • 下呼吸道淀粉样变性分气管支气管、结节、间质和复合模式,与吸烟、器官受累范围和合并症相关
  • 心脏受累(HR 4.3)、年龄(HR 2.1)和诊断时呼吸困难(HR 4.0)为独立死亡危险因素

核心结论

  • 下呼吸道淀粉样变性不同呼吸模式与吸烟习惯、器官局限或多器官受累及合并症相关,生存期不同,并可由年龄、心脏受累和诊断时呼吸困难预测。

研究设计与样本

  • 多中心回顾性研究,1995至2017年纳入73例下呼吸道受累的淀粉样变性患者。

主要发现

  • 呼吸模式:气管支气管17例、结节10例、间质14例、复合32例。
  • 间质和复合模式与多器官淀粉样变性相关(37例,80%),气管支气管和结节模式与器官局限型相关(21例,78%)。
  • AL型淀粉样变性43例(59%),其中λ型33例(77%)。
  • 吸烟者比例在气管支气管型(71%)和结节型(90%)高于间质型(14%)和复合型(34%)。

关键数值与推荐

  • 呼吸模式分为气管支气管、结节、间质或复合(多种呼吸受累)。
  • B细胞肿瘤累及15例(21%),实体肿瘤8例(11%),结缔组织病8例(11%),多发性骨髓瘤6例(8%)。

临床怎么用

  • 下呼吸道淀粉样变性评估应结合呼吸模式、吸烟史、器官受累范围及合并症。
  • 诊断时需关注心脏受累、年龄和呼吸困难,以评估死亡风险。
  • 气管支气管和结节模式患者生存相对较好,间质和复合模式需警惕多器官受累。

局限性

  • 回顾性研究设计。
  • 样本量较小(73例)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Lower-respiratory-tract (LRT) amyloidosis has rarely been investigated. Our study presents characteristics, outcomes and survival of LRT amyloidosis. This multicenter retrospective study, from 1995 to 2017, included 73 patients with amyloidosis and LRT involvement. Respiratory patterns were: tracheobronchial (n = 17), nodular (n = 10), interstitial (n = 14) or composite (several respiratory involvements, n = 32). Interstitial and composite patterns were associated with multi-organ amyloidosis (n = 37, 80%) while tracheobronchial and nodular patterns were associated with organ-limited amyloidosis (n = 21, 78%). Amyloid light chain (AL) amyloidosis was diagnosed in 43 patients (59%), mainly of lambda type (n = 33, 77%). Smokers' proportion was higher in tracheobronchial (71%) and nodular (90%) patterns than in interstitial (14%) and composite (34%) patterns. The B-cell neoplasms involved 15 patients (21%), solid neoplasms 8 (11%), connective tissue diseases 8 (11%) and multiple myeloma 6 (8%). The B-cell and solid neoplasms were most prevalent in nodular pattern. Median follow-up was 4.4 years (2.2-8.9). Twenty-four patients died, mostly from respiratory infection. Survival at 1, 5, 10 years was respectively 88%, 70% and 54% for multi-organ amyloidosis, 96%, 89% and 69% for organ-limited amyloidosis (P = .125). Tracheobronchial and nodular patterns survival was better than in other respiratory patterns (P = .039). Death risk factors (multivariate analysis) were: cardiac localization (hazard-ratio [HR] 4.3 [95% confidence interval 1.6-11.5]; P = .004), age (HR 2.1 [1.2-3.7]; P = .008) and dyspnea at diagnosis (HR 4.0 [1.3-12.3]; P = .014). Various LRT amyloidosis patterns depend on smoking habits, organ-limited or multi-organ extension and comorbidities. They are associated with a different survival, which is also predicted by age, cardiac localization and dyspnea at presentation.

来源:Am J Hematol,查看原文。版权归原作者所有。

引用

  1. Rech JS, Arnulf B, de Margerie-Mellon C, et al. Lower respiratory tract amyloidosis: Presentation, survival and prognostic factors. A multicenter consecutive case series. Am J Hematol. 2019. PMID: 31396978. doi:10.1002/ajh.25608

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。